Commodore Capital LP Diversified Active

CIK: 0001831942 · Show all filings

Period: Q3 2023 (← Previous) (Next →)

Filing Date: Nov 14, 2023

Total Value ($000): $855,509 (100.0% shares, 0.0% debt)

Holdings (30)

MERUS N V 12.2%
Value ($000) $104,414 Shares 4,428,072 Est. Cost $24.58 Unrealized
VERA VERA THERAPEUTICS INC 8.7%
Value ($000) $74,720 Shares 5,450,000 Est. Cost $8.35 Unrealized +105.4%
XENE XENON PHARMACEUTICALS INC 7.4%
Value ($000) $63,025 Shares 1,845,000 Est. Cost $26.06 Unrealized +43.5%
PCVX VAXCYTE INC 6.6%
Value ($000) $56,078 Shares 1,100,000 Est. Cost $46.14 Unrealized +6.9%
COGT COGENT BIOSCIENCES INC 6.3%
Value ($000) $54,269 Shares 5,566,026 Est. Cost $8.92 Unrealized +32.9%
RYTM RHYTHM PHARMACEUTICALS INC 5.6%
Value ($000) $47,569 Shares 2,075,000 Est. Cost $22.39 Unrealized 0.0%
AMBRX BIOPHARMA INC 4.7%
Value ($000) $40,463 Shares 3,518,556 Est. Cost $9.17 Unrealized
ELVN ENLIVEN THERAPEUTICS INC 4.6%
Value ($000) $39,639 Shares 2,901,816 Est. Cost $19.64 Unrealized -14.3%
CABA CABALETTA BIO INC 4.5%
Value ($000) $38,442 Shares 2,525,753 Est. Cost $7.66 Unrealized +78.5%
IMVT IMMUNOVANT INC 4.5%
Value ($000) $38,390 Shares 1,000,000 Est. Cost $14.46 Unrealized +56.4%
NUVL NUVALENT INC 4.5%
Value ($000) $38,099 Shares 828,778 Est. Cost $28.77 Unrealized +54.3%
VRDN VIRIDIAN THERAPEUTICS INC 3.9%
Value ($000) $33,748 Shares 2,200,000 Est. Cost $17.59 Unrealized +8.5%
AKERO THERAPEUTICS INC 3.3%
Value ($000) $28,578 Shares 565,000 Est. Cost $41.36 Unrealized
SLNO SOLENO THERAPEUTICS INC 3.1%
Value ($000) $26,190 Shares 887,500 Est. Cost $6.05 Unrealized 0.0%
IDYA IDEAYA BIOSCIENCES INC 2.4%
Value ($000) $20,910 Shares 775,000 Est. Cost $20.56 Unrealized +23.3%
CLDX CELLDEX THERAPEUTICS INC NEW 2.3%
Value ($000) $19,447 Shares 706,665 Est. Cost $31.10 Unrealized +0.8%
CELC CELCUITY INC 1.8%
Value ($000) $15,484 Shares 1,694,141 Est. Cost $18.50 Unrealized -46.8%
ALPINE IMMUNE SCIENCES INC 1.8%
Value ($000) $15,171 Shares 1,325,000 Est. Cost $7.20 Unrealized
ADVERUM BIOTECHNOLOGIES INC 1.8%
Value ($000) $15,000 Shares 10,000,000 Est. Cost $1.15 Unrealized
CRNX CRINETICS PHARMACEUTICALS IN 1.7%
Value ($000) $14,870 Shares 500,000 Est. Cost $20.61 Unrealized 0.0%
SNDX SYNDAX PHARMACEUTICALS INC 1.6%
Value ($000) $13,903 Shares 957,509 Est. Cost $22.61 Unrealized -16.3%
KURA KURA ONCOLOGY INC 1.5%
Value ($000) $12,768 Shares 1,400,000 Est. Cost $13.92 Unrealized -27.1%
THIRD HARMONIC BIO INC 1.3%
Value ($000) $10,863 Shares 1,700,000 Est. Cost $13.74 Unrealized
DAWN DAY ONE BIOPHARMACEUTICALS I 1.1%
Value ($000) $9,076 Shares 739,661 Est. Cost $10.33 Unrealized +26.3%
VTGN VISTAGEN THERAPEUTICS INC 1.0%
Value ($000) $8,253 Shares 1,575,000 Est. Cost $4.44 Unrealized 0.0%
RAYZEBIO INC 0.7%
Value ($000) $6,414 Shares 288,911 Est. Cost $22.20 Unrealized
APGE APOGEE THERAPEUTICS INC 0.6%
Value ($000) $5,325 Shares 250,000 Est. Cost $22.03 Unrealized 0.0%
MERSANA THERAPEUTICS INC 0.3%
Value ($000) $2,850 Shares 2,244,378 Est. Cost $1.27 Unrealized
SYRE AEGLEA BIOTHERAPEUTICS INC 0.2%
Value ($000) $1,425 Shares 116,324 Est. Cost $13.22 Unrealized 0.0%
DBV TECHNOLOGIES S A 0.0%
Value ($000) $126 Shares 92,687 Est. Cost $0.00 Unrealized